Today: 10 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

PepsiCo Stock (PEP) News Today: 2026 Outlook, Elliott-Backed Cost Cuts, Analyst Targets, and Lawsuit Risks (Dec. 22, 2025)

PepsiCo Stock (PEP) News Today: 2026 Outlook, Elliott-Backed Cost Cuts, Analyst Targets, and Lawsuit Risks (Dec. 22, 2025)

PepsiCo shares traded near $146.5 on Dec. 22, 2025, down about 1% as investors weighed a new 2026 strategy shaped by Elliott Investment Management and a legal probe into U.S. pricing practices. The company’s market cap stood at roughly $203 billion, with a dividend yield near 3.9%. PepsiCo’s updated priorities include cost cuts, portfolio simplification, and a focus on affordability. Q4 results are due Feb. 3, 2026.
22 December 2025
··
Sandisk (SNDK) Stock News Today: Price Action, Analyst Targets, and 2026 Outlook as the AI NAND Cycle Accelerates (Dec. 22, 2025)

Sandisk (SNDK) Stock News Today: Price Action, Analyst Targets, and 2026 Outlook as the AI NAND Cycle Accelerates (Dec. 22, 2025)

Sandisk shares climbed 1.7% to $242 on December 22, 2025, extending steep gains for the year as AI-driven infrastructure spending fuels flash memory demand. Perpetual Ltd disclosed a new institutional stake, while analysts point to strong Q1 FY2026 results and raised guidance, with revenue up 21% sequentially to $2.31 billion.
22 December 2025
·
Coca-Cola Stock Today: KO Holds Near $70 as CEO Transition, Dividend Focus, and 2026 Catalysts Shape the Outlook

Coca-Cola Stock Today: KO Holds Near $70 as CEO Transition, Dividend Focus, and 2026 Catalysts Shape the Outlook

Coca-Cola shares hovered near $70 on December 22, trading in a narrow range with modest volume. CCLA Investment Management and Flputnam Investment Management both increased their stakes in the third quarter, while company insiders sold over 225,000 shares in the past 90 days. Leadership succession and valuation debates remain in focus as 2026 approaches.
22 December 2025
··
Coinbase Global, Inc. (COIN) Stock Update: Prediction-Market Acquisition, “Everything Exchange” Rollout, and Analyst Forecasts on 22.12.2025

Coinbase Global, Inc. (COIN) Stock Update: Prediction-Market Acquisition, “Everything Exchange” Rollout, and Analyst Forecasts on 22.12.2025

Coinbase said Dec. 22 it will acquire prediction markets startup The Clearing Company, its 10th deal this year, to expand beyond crypto trading. COIN shares closed up 1.77% at $249.45 after the announcement. The company expects the deal to close in January 2026; terms were not disclosed. Coinbase is pushing into new markets as part of a broader “super app” strategy.
22 December 2025
···
Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen shares traded near $175 on Dec. 22 as the company announced JAMA Neurology published final long-term results from its Phase 3 VALOR study of QALSODY for SOD1-ALS. The stock was removed from the Nasdaq-100 index today, following a surge in volume last Friday. Analyst ratings remain mixed, with price targets ranging from the low-$140s to above $200.
22 December 2025
·
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

BioMarin agreed to acquire Amicus Therapeutics for $14.50 per share in cash, valuing Amicus at $4.8 billion. FOLD traded near $14.22 on December 22, reflecting market expectations for deal completion and timing. The transaction is expected to close in Q2 2026, pending regulatory and shareholder approvals. Either party may terminate if not closed by June 19, 2026, with a $175 million breakup fee.
22 December 2025
··
KLA Corporation Stock (KLAC) News and Forecasts on Dec. 22, 2025: Analyst Upgrades, AI Capex Tailwinds, and China Risk

KLA Corporation Stock (KLAC) News and Forecasts on Dec. 22, 2025: Analyst Upgrades, AI Capex Tailwinds, and China Risk

KLA shares rose after Jefferies upgraded the stock to “Buy” and raised its price target to $1,500, citing strong AI-driven demand for semiconductor equipment. Multiple analysts highlighted KLA as a top pick for 2026, pointing to increased process-control needs in advanced chip manufacturing. Investors remain cautious about the company’s exposure to China and U.S. export controls.
22 December 2025
···
Uber Technologies (UBER) Stock Rallies on Baidu Robotaxi London Deal: Today’s News, Analyst Forecasts, and 2026 Outlook (Dec. 22, 2025)

Uber Technologies (UBER) Stock Rallies on Baidu Robotaxi London Deal: Today’s News, Analyst Forecasts, and 2026 Outlook (Dec. 22, 2025)

Uber shares rose 2.36% to $81.18 on Dec. 22 after the company announced a partnership with Lyft and Baidu to launch Apollo Go robotaxi trials in London in 2026. The move follows the U.K.’s Automated Vehicles Act, which shifts liability to companies. Baidu’s Apollo Go RT6 vehicles will join Uber and Lyft’s London networks, pending regulatory approval.
22 December 2025
····
Hecla Mining Stock (HL) Surges on S&P MidCap 400 Inclusion and Record Silver Prices: News, Forecasts, and 2026 Outlook (Dec. 22, 2025)

Hecla Mining Stock (HL) Surges on S&P MidCap 400 Inclusion and Record Silver Prices: News, Forecasts, and 2026 Outlook (Dec. 22, 2025)

Hecla Mining shares jumped over 4% on December 22, 2025, after joining the S&P MidCap 400 and as silver hit a record $69.44. HL traded around $20.38 by midday, up $0.71. Gold also broke above $4,400 for the first time. Hecla recently reported record Q3 revenue of $409.5 million and net income of $100.6 million.
22 December 2025
···
Procter & Gamble Stock (NYSE: PG) Today: Latest News, Analyst Forecasts, and What to Watch Into 2026 (Dec. 22, 2025)

Procter & Gamble Stock (NYSE: PG) Today: Latest News, Analyst Forecasts, and What to Watch Into 2026 (Dec. 22, 2025)

Procter & Gamble shares closed at $142.91 on Dec. 22, 2025, near the lower end of their 52-week range after management warned of volatile U.S. demand and cautious consumers. The company cited weaker October sales and macro disruptions, including a government shutdown and delayed SNAP benefits. Market cap stands at about $334 billion, with a dividend yield near 3%. Next earnings are set for Jan. 22, 2026.
22 December 2025
·
GE Vernova Stock (NYSE: GEV) News on Dec. 22, 2025: Offshore Wind Freeze, New HVDC Contract, and Wall Street Forecasts

GE Vernova Stock (NYSE: GEV) News on Dec. 22, 2025: Offshore Wind Freeze, New HVDC Contract, and Wall Street Forecasts

GE Vernova shares traded near $661 Monday afternoon after opening higher and swinging between the mid-$650s and low-$670s. The Trump administration ordered a halt to five U.S. offshore wind projects, raising new schedule risks for GE Vernova’s involvement in Vineyard Wind. Separately, the company secured a major HVDC contract in India with Adani Energy Solutions for a 2.5 GW transmission corridor.
22 December 2025
···
American Express (AXP) Stock News Today (Dec. 22, 2025): Truist Lifts Price Target to $420 as Holiday Spending, Credit Trends, and Dividends Stay in Focus

American Express (AXP) Stock News Today (Dec. 22, 2025): Truist Lifts Price Target to $420 as Holiday Spending, Credit Trends, and Dividends Stay in Focus

American Express shares rose about 1.2% to $381 on December 22, 2025, after Truist Securities raised its price target to $420. The move came amid strong premium-card spending and steady credit metrics, with no major earnings or acquisition news. CEO Stephen Squeri reported 9% growth in U.S. retail spending over Thanksgiving, including a 13% jump for Platinum cards. Delinquency rates remained steady, while write-offs edged higher.
22 December 2025
··
Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences said Monday it will license Assembly Biosciences’ investigational herpes simplex virus programs, including two oral candidates, for a $35 million payment. The move expands Gilead’s antiviral pipeline days after it joined a Trump administration drug-pricing deal. Shares traded around $123–$124, slightly lower on the day. No new HSV therapies have been approved in the U.S. or Europe for over 25 years.
22 December 2025
·
Intuit Stock (INTU) Today: Stablecoin Push With Circle, OpenAI Deal, and 2026 Tax Season Catalysts Investors Are Watching

Intuit Stock (INTU) Today: Stablecoin Push With Circle, OpenAI Deal, and 2026 Tax Season Catalysts Investors Are Watching

Intuit shares rose 0.65% to $675.71 on December 22 after the company highlighted a new stablecoin partnership with Circle, aiming to use USDC for faster payments across TurboTax, QuickBooks, and Credit Karma. CFO Sandeep Aujla called stablecoins a “digital dollar rail” for everyday transactions, positioning the move as an infrastructure upgrade. Implementation details and regulatory questions remain.
22 December 2025
···
Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing shares rose about 1.1% to $216.39 on December 22, 2025, after trading between $214.22 and $217.09. The move comes as the company reports supplier defect reductions and seeks an FAA waiver to continue selling 777F freighters. An Air India Boeing 777 incident is under investigation but did not involve injuries. Year-to-date, Boeing stock is up roughly 22%.
22 December 2025
·
Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron shares rose about 1.6% to $150 midday Monday, helping drive the Dow higher as oil prices climbed on Venezuela supply concerns. Reuters reported Chevron exported a 500,000-barrel Venezuelan oil cargo to the U.S. Sunday, with deliveries reportedly uninterrupted despite tanker slowdowns and operational issues in Venezuela.
22 December 2025
···
Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed joined the Nasdaq-100 Index on December 22, 2025, boosting its stock visibility. Shares traded at $177.86, up 1.7%, after recent swings triggered by a failed Phase 2b trial for brensocatib in chronic rhinosinusitis, which led the company to end that program. Insmed also acquired INS1148, a Phase 2–ready monoclonal antibody, for $40 million upfront.
22 December 2025
·
1 … 512 513 514 515 516 … 695
Go toTop